Metagenomics Market (Product Type: Instruments, Kits & Reagents, and Software & Services; and Technology: 16S Sequencing, Whole Genome Sequencing, Shotgun Sequencing, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-

Metagenomics Market (Product Type: Instruments, Kits & Reagents, and Software & Services; and Technology: 16S Sequencing, Whole Genome Sequencing, Shotgun Sequencing, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


Metagenomics Market – Scope of Report

TMR’s report on the global metagenomics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global metagenomics market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global metagenomics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the metagenomics market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global metagenomics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global metagenomics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global metagenomics market.

The report delves into the competitive landscape of the global metagenomics market. Key players operating in the global metagenomics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global metagenomics market profiled in this report.

Key Questions Answered in Global metagenomics Market Report
  • What is the sales/revenue generated by metagenomics across all regions during the forecast period?
  • What are the opportunities in the global metagenomics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Metagenomics Market – Research Objectives and Research Approach

The comprehensive report on the global metagenomics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global metagenomics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global metagenomics market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Metagenomics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Metagenomics Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Metagenomics Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Instruments
6.3.2. Kits & Reagents
6.3.3. Software & Services
6.4. Market Attractiveness Analysis, by Product Type
7. Global Metagenomics Market Analysis and Forecast, by Technology
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2017–2031
7.3.1. 16S Sequencing
7.3.2. Whole Genome Sequencing
7.3.3. Shotgun Sequencing
7.3.4. Others
7.4. Market Attractiveness Analysis, by Technology
8. Global Metagenomics Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Ecology & Environment
8.3.2. Clinical Diagnostics
8.3.3. Drug Discovery
8.3.4. Biotechnology
8.3.5. Food & Beverages
8.3.6. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Metagenomics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Metagenomics Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product Type, 2017–2031
10.3.1. Instruments
10.3.2. Kits & Reagents
10.3.3. Software & Services
10.4. Market Value Forecast, by Technology, 2017–2031
10.4.1. 16S Sequencing
10.4.2. Whole Genome Sequencing
10.4.3. Shotgun Sequencing
10.4.4. Others
10.5. Market Value Forecast, by Application, 2017–2031
10.5.1. Ecology & Environment
10.5.2. Clinical Diagnostics
10.5.3. Drug Discovery
10.5.4. Biotechnology
10.5.5. Food & Beverages
10.5.6. Others
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product Type
10.7.2. By Technology
10.7.3. By Application
10.7.4. By Country
11. Europe Metagenomics Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product Type, 2017–2031
11.3.1. Instruments
11.3.2. Kits & Reagents
11.3.3. Software & Services
11.4. Market Value Forecast, by Technology, 2017–2031
11.4.1. 16S Sequencing
11.4.2. Whole Genome Sequencing
11.4.3. Shotgun Sequencing
11.4.4. Others
11.5. Market Value Forecast, by Application, 2017–2031
11.5.1. Ecology & Environment
11.5.2. Clinical Diagnostics
11.5.3. Drug Discovery
11.5.4. Biotechnology
11.5.5. Food & Beverages
11.5.6. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Technology
11.7.3. By Application
11.7.4. By Country/Sub-region
12. Asia Pacific Metagenomics Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product Type, 2017–2031
12.3.1. Instruments
12.3.2. Kits & Reagents
12.3.3. Software & Services
12.4. Market Value Forecast, by Technology, 2017–2031
12.4.1. 16S Sequencing
12.4.2. Whole Genome Sequencing
12.4.3. Shotgun Sequencing
12.4.4. Others
12.5. Market Value Forecast, by Application, 2017–2031
12.5.1. Ecology & Environment
12.5.2. Clinical Diagnostics
12.5.3. Drug Discovery
12.5.4. Biotechnology
12.5.5. Food & Beverages
12.5.6. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Technology
12.7.3. By Application
12.7.4. By Country/Sub-region
13. Latin America Metagenomics Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product Type, 2017–2031
13.3.1. Instruments
13.3.2. Kits & Reagents
13.3.3. Software & Services
13.4. Market Value Forecast, by Technology, 2017–2031
13.4.1. 16S Sequencing
13.4.2. Whole Genome Sequencing
13.4.3. Shotgun Sequencing
13.4.4. Others
13.5. Market Value Forecast, by Application, 2017–2031
13.5.1. Ecology & Environment
13.5.2. Clinical Diagnostics
13.5.3. Drug Discovery
13.5.4. Biotechnology
13.5.5. Food & Beverages
13.5.6. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Technology
13.7.3. By Application
13.7.4. By Country/Sub-region
14. Middle East & Africa Metagenomics Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product Type, 2017–2031
14.3.1. Instruments
14.3.2. Kits & Reagents
14.3.3. Software & Services
14.4. Market Value Forecast, by Technology, 2017–2031
14.4.1. 16S Sequencing
14.4.2. Whole Genome Sequencing
14.4.3. Shotgun Sequencing
14.4.4. Others
14.5. Market Value Forecast, by Application, 2017–2031
14.5.1. Ecology & Environment
14.5.2. Clinical Diagnostics
14.5.3. Drug Discovery
14.5.4. Biotechnology
14.5.5. Food & Beverages
14.5.6. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Technology
14.7.3. By Application
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Thermo Fisher Scientific, Inc.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. QIAGEN
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Illumina, Inc.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Promega Corporation
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Novogene Co., Ltd.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Takara Bio Inc.
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Oxford Nanopore Technologies plc
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Arc Bio, LLC
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Eurofins Scientific
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Zymo Research
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Microsynth AG
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. F. Hoffmann-La Roche Ltd.
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview
15.3.13. PerkinElmer, Inc.
15.3.13.1. Company Overview
15.3.13.2. Product Portfolio
15.3.13.3. SWOT Analysis
15.3.13.4. Financial Overview
15.3.13.5. Strategic Overview
15.3.14. Computomics GmbH
15.3.14.1. Company Overview
15.3.14.2. Product Portfolio
15.3.14.3. SWOT Analysis
15.3.14.4. Financial Overview
15.3.14.5. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings